Chief Executive Officer

SERB Pharmaceuticals Acquires Y-mAbs Therapeutics in $412 Million All-Cash Transaction

SERB Pharmaceuticals Completes Acquisition of Y-mAbs Therapeutics

Top biotech deals in August 2025

Radiopharma’s big year: Interview with RadioMedix CEO Dr. Delpassand

Senior Director, Pricing & Contracting

SERB Pharmaceuticals is seeking a Senior Director, Pricing & Contracting to lead the development and oversight of pricing strategies and contracting frameworks. The role involves collaboration with various teams to ensure operational excellence and compliance for the company's US portfolio.

Sign up with Google

Sign in with Google